Ancora Advisors’s VolitionRx Ltd VNRX Stock Holding History

Ancora Advisors’s Portfolio VNRX Stock Details VNRX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-5	Closed	-$191	–	1925
2023 Q1	$191	Buy	+5	New	+$209	﹤0.01%	1849

Other funds holding VNRX

LIM

Lagoda Investment Management New York $162M AUM 49.7% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

CPA

Cowen Prime Advisors New York $290M AUM 57.8% 1-Year Est. Return

BCM

Bridgeway Capital Management Houston, Texas $4.97B AUM 44.96% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

SAMC

Spectrum Asset Management (California) Newport Beach, California $315M AUM 19.93% 1-Year Est. Return

Ancora Advisors's VNRX Position: Q2 2023 in Review

Ancora Advisors sold out of VolitionRx Ltd (VNRX) in Q2 2023, closing a stake of 5 shares — an estimated $191 sold.

Ancora Advisors first reported a position in VNRX in Q1 2023 and held it in 1 quarter. The position peaked at $191 in Q1 2023. 34 funds tracked by Wall St. Rank hold VNRX as of Q2 2023.

Ancora Advisors reported no remaining VolitionRx Ltd position as of Q2 2023 after selling out during the quarter.
Ancora Advisors sold 5 VolitionRx Ltd shares in Q2 2023, an estimated $191.
Ancora Advisors first reported a position in VolitionRx Ltd in Q1 2023 and held it in 1 quarter.
Ancora Advisors's VolitionRx Ltd position peaked at $191 in Q1 2023.
34 funds tracked by Wall St. Rank held VolitionRx Ltd as of Q2 2023.

Based on Ancora Advisors's 13F filing for Q2 2023, filed 14 Aug 2023.